window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-113618785-3');

EUPHORIA presented at Translating Documentation and Communication in Clinical Research Conference

By |2020-11-26T13:28:12+00:00November 26th, 2020|

On November 24, 2020, Deborah-Ann Schuster, Clinical Trial Manager at iThera Medical was an invited speaker at the Translating Documentation and Communication in Clinical Research 2020 Virtual Conference. In her talk titled “What Do You Need To Know When Translating Your Regulatory Document?”, Deborah-Ann presented EUPHORIA as the case study for the translation requirements with [...]

The EUPHORIA newsletter is available

By |2020-11-26T12:24:43+00:00November 26th, 2020|

The EUPHORIA team has been extremely busy these last many months. We have put in the place the groundwork for our clinical study, presented at conferences and submitted ground-breaking work for publication. Read a recap of all of our activity in our new project newsletter. It includes an interview with RAYFOS CEO Vassilis Sarantos and [...]

SME RayFos in the EUPHORIA Spotlight

By |2020-11-09T15:55:22+00:00November 9th, 2020|

Headquartered in Basingstoke in the south of England with eight employees, RayFos Limited is active in the optical engineering and real-time processing systems domain. This innovative scientific software firm specializes in advanced signal processing system integration for a variety of measurement applications. Established in 2012, RayFos provides state-of-the-art solutions tailored to the needs and business [...]

PRESS RELEASE: Approval for EUPHORIA’s pivotal clinical trial to assess colon inflammation in patients with inflammatory bowel disease

By |2020-10-29T12:25:03+00:00October 20th, 2020|

Munich, DE – Medical device company iThera Medical announces regulatory approval for a pivotal multi-center trial in patients with inflammatory bowel disease (IBD). The  EUPHORIA (Enhancing Ultrasound & Photoacoustics for Recognition of Intestinal Abnormalities) clinical trial will commence at four investigational sites across Germany and Italy using iThera Medical’s proprietary optoacoustic imaging technology, MSOT (multispectral [...]

iThera Webinar: Imaging Lymphatic Disorders with Optoacoustic Tomography

By |2020-07-13T12:04:28+01:00July 13th, 2020|

Join the July 16th webinar hosted by EUPHORIA Co-ordinator iThera Medical, 3:00-4:00 BST. Hear Dr Guido Giacalone, Head of the Department of Lymphatic Surgery at AZ Sint-Maarten (Mechelen, Belgium) outline his work in the field and the use of MSOT for preoperative mapping of lymphatic and blood vessels. Particular topics covered include: - An overview [...]

The EUPHORIA clinical study is officially registered!

By |2020-07-29T15:23:44+01:00July 8th, 2020|

The clinical trial "Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities (EUPHORIA)" is officially registered with as of July 2nd, 2020. Read the details here. There, you will find the study design, patient cohort information, the outcome measures and the eligibility criteria. The clinical investigation aims to generate clinical data to support the [...]

iThera Webinar: Multi-scale Clinical Optoacoustic Skin Imaging

By |2020-06-18T16:51:07+01:00June 18th, 2020|

EUPHORIA Coordinator iThera Medical is hosting a webinar on June 25th. The topic: Multi-Scale Clinical Optoacoustic Skin Imaging. Dr Dinish U. S and Dr Chris Ho of the Singapore Bioimaging Consortium (SBIC) will present on the use of Multispectral Optoacoustic Tomography (MSOT) to study morphological and functional changes associated with skin cancers in 2D and [...]

iThera Webinar: Optoacoustics and Optical: Complementary Modalities for Molecular Imaging

By |2020-05-18T15:07:02+01:00May 18th, 2020|

Both optoacoustic and optical imaging are biophotonic imaging technologies. While optoacoustic imaging yields information about light absorption from both endogenous tissue chromophores and optical contrast agents, optical imaging only provides information from extrinsically administered agents by means of light emission (fluorescence or bioluminescence). In terms of performance, optical imaging can serve as an easy-to-use screening [...]

EUPHORIA joins EU-funded New Deal for live Twitter chat to explore the future of IBD treatment

By |2020-04-28T12:00:01+01:00April 28th, 2020|

Professor Dr Max Waldner of University Hospital Erlangen participated in a live Twitter chat on Monday, April 27, 2020. The chat was hosted by Bruno Martin of ScienSeed, a partner on the New Deal, an EU Horizon 2020 funded project and one of EUPHORIA's "Related Projects". Joining Max and Bruno was Dr Azucena Salas, a [...]

EUPHORIA explainer film is launched!

By |2020-03-12T12:59:18+00:00March 11th, 2020|

EUPHORIA coordinators at iThera Medical Gmbh have produced a short explainer film to showcase the emerging diagnostic imaging technology, Multispectral Optoacoustic Tomography or MSOT for monitoring and managing inflammatory bowel disease. Watch it here  Since 2010, iThera Medical has been selling successfully worldwide into the pre-clinical research imaging market. iThera Medical has established a global distribution [...]

Go to Top